Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rejuvenate Healthcare is a private U.S. healthcare services company focused on accelerating kidney transplantation for people with kidney failure and reducing the clinical and financial burden of dialysis. The company works primarily with self-insured employers, health plans, TPAs, brokers, insurers and captives, using a data-driven patient identification and care-navigation model to move eligible patients to transplant faster. Its offering combines early identification of at-risk patients, transplant qualification support, and post-transplant coaching, rather than developing drugs or traditional therapeutics. Rejuvenate positions its approach as an alternative to dialysis-centric kidney care management, aiming to improve patient survival and lower end-stage renal disease costs for payers. The business appears to operate commercially under the Rejuvenate Healthcare brand, while the requested name corresponds to its earlier operating name, Rejuvenate Kidney Transplant Solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rejuvenate Healthcare.